Articles

Aiyisheng Completes Angel Round with DaoTong as Sole Investor, Accelerating Clinical Trials for Small-Caliber Artificial Blood Vessels | DaoTong News

Aiyisheng Completes Angel Round with DaoTong as Sole Investor, Accelerating Clinical Trials for Small-Caliber Artificial Blood Vessels | DaoTong News

Recently, **Aison (Guangzhou) Biotech Co., Ltd.** (hereinafter referred to as Aison Medical) **announced the completion of its angel round, led exclusively by Dalton Venture.** The proceeds will be primarily used to advance the clinical development of small-diameter artificial blood vessels and to expand applications of its core technology.